Tigecycline molecule, MRSA antibiotic

Tigecycline molecule, MRSA antibiotic

A624/0183 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 34.3MB

Downloadable file size: 306.1KB

Price image Pricing

Please login to use the price calculator


Caption: Tigecycline molecule. Computer model of a molecule of the MRSA antibiotic drug tigecycline (brand name Tygacil, chemical formula C29.H39.N5.O8). Atoms (tubes) are colour-coded: carbon (green), hydrogen (grey), nitrogen (purple) and oxygen (orange). The drug has been developed to treat drug-resistant bacterial infections including, but not restricted to, methicillin-resistant Staphylococcus aureus (MRSA) bacterial infections. These infections kill many people because the bacteria have developed a resistance to normal antibiotic drugs. Tigecycline was developed by the Wyeth pharmaceutical company, and medical trials started in 2004.

Release details: Model release not required. Property release not required.

Keywords: antibiotic, artwork, atomic, atoms, bacterial, biochemical, biochemistry, chemical, chemistry, computer artwork, drug, drug resistance, illustration, infection, medical, medicine, methicillin-resistant, model, molecular, molecule, mrsa, pharmaceutical, pharmaceutics, pharmacological, pharmacology, staphylococcus aureus, structural, structure, superbug, superdrug, tigacil, tigecycline, treatment, tube, tubes, tubular, vancomycin-resistant, vrsa

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.